Bicocca Open Archive

Logo unimib boa
PIROLA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.158
EU - Europa 3.409
AS - Asia 3.321
SA - Sud America 501
Continente sconosciuto - Info sul continente non disponibili 400
AF - Africa 78
OC - Oceania 15
Totale 15.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.780
SG - Singapore 1.188
CN - Cina 753
IT - Italia 711
DE - Germania 662
VN - Vietnam 430
RU - Federazione Russa 414
SE - Svezia 400
BR - Brasile 372
HK - Hong Kong 364
IE - Irlanda 324
CA - Canada 304
GB - Regno Unito 215
UA - Ucraina 196
FR - Francia 171
IN - India 121
FI - Finlandia 81
TR - Turchia 69
BD - Bangladesh 66
AR - Argentina 46
ID - Indonesia 44
IQ - Iraq 43
PL - Polonia 40
KR - Corea 39
JP - Giappone 37
DK - Danimarca 34
ES - Italia 34
MX - Messico 32
BE - Belgio 31
ZA - Sudafrica 30
PK - Pakistan 27
NL - Olanda 25
CO - Colombia 21
SA - Arabia Saudita 19
AT - Austria 18
EC - Ecuador 17
PH - Filippine 15
VE - Venezuela 15
AU - Australia 13
UZ - Uzbekistan 13
CH - Svizzera 12
CL - Cile 10
JO - Giordania 10
KE - Kenya 10
LT - Lituania 10
IR - Iran 9
MA - Marocco 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
NP - Nepal 7
OM - Oman 7
PE - Perù 7
PY - Paraguay 7
AZ - Azerbaigian 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
PS - Palestinian Territory 5
TH - Thailandia 5
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
MU - Mauritius 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
LY - Libia 2
MG - Madagascar 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
Totale 15.472
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.069
Ashburn 870
Singapore 694
San Jose 453
Woodbridge 418
Fairfield 378
Houston 356
Frankfurt am Main 350
Hong Kong 350
Chandler 348
Milan 320
Dublin 315
Wilmington 252
Dearborn 225
Toronto 188
Jacksonville 179
New York 176
Seattle 171
Los Angeles 158
Beijing 138
Cambridge 123
Ho Chi Minh City 119
Santa Clara 110
Council Bluffs 93
Princeton 92
Dallas 90
Hanoi 88
Chicago 85
The Dalles 74
Nanjing 65
Göttingen 61
Shanghai 58
Boardman 53
Lauterbourg 50
São Paulo 49
Munich 46
Buffalo 44
Altamura 37
Lawrence 36
Moscow 36
Orem 34
Seoul 34
Hefei 32
Jakarta 32
Brussels 31
Helsinki 31
Lachine 29
Rome 29
Ottawa 28
Nanchang 26
San Diego 26
London 25
Shenyang 25
Montreal 24
Warsaw 24
Dong Ket 23
Columbus 22
Da Nang 22
Guangzhou 22
Phoenix 22
Denver 21
Fürstenwalde 21
Tokyo 21
Atlanta 20
Johannesburg 20
Andover 19
Fremont 19
Kocaeli 19
Baghdad 18
Brooklyn 18
Chennai 18
Falls Church 17
Washington 17
Hebei 16
Nuremberg 16
Tianjin 16
Changsha 15
Stockholm 15
Haiphong 14
Boston 13
Lissone 13
Manchester 13
Pune 13
Brasília 12
Charlotte 12
Jiaxing 12
Jinan 12
Kunming 12
Mumbai 12
Turin 12
Ankara 11
Edmonton 11
Lahore 11
Norwalk 11
San Francisco 11
Tashkent 11
Amman 10
Can Tho 10
Mexico City 10
Pavia 10
Totale 9.940
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 645
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 541
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 492
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 480
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 478
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 469
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 445
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 437
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 419
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 418
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 416
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 416
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 411
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 404
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 403
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 377
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 370
Whole-Exome Sequencing Data - Identifying Somatic Mutations 370
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 352
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 352
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 340
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 338
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 332
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 331
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 329
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 329
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 328
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 327
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 318
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 303
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 302
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 292
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 291
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 286
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 279
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 279
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 275
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 275
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 264
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 264
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 247
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 240
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 223
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 220
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 175
Totale 15.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 0 0 0 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.919 135 166 120 97 194 74 113 72 164 360 161 263
2025/20265.081 610 209 387 595 622 251 761 173 408 478 304 283
2026/20271.148 155 185 431 377 0 0 0 0 0 0 0 0
Totale 15.882